Marksans Pharma board recommends dividend

31 May 2022 Evaluate
Marksans Pharma has informed that the Board of Directors of the Company at its meeting held on May 30, 2022, has recommended final dividend at Re 0.25 (Rupee Zero and Paise Twenty Five), 25% per equity share of Re 1 each face value for the financial year ended March 31, 2022, subject to approval of the shareholders in the ensuing Annual General Meeting.

The above information is a part of company’s filings submitted to BSE.

Marksans Pharma Share Price

163.10 -6.85 (-4.03%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×